國立虎尾科技大學 |

Cytokine storm syndrome

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Cytokine storm syndrome/ edited by Randy Q. Cron, Edward M. Behrens.
其他作者:	Behrens, Edward M.
出版者:	Cham :Springer International Publishing : : 2024.,
面頁冊數:	xvi, 628 p. :ill. (some col.), digital ; : 24 cm.;
Contained By:	Springer Nature eBook
標題:	Cytokines and Growth Factors. -
電子資源:	https://doi.org/10.1007/978-3-031-59815-9
ISBN:	9783031598159

Cytokine storm syndrome
Cytokine storm syndrome[electronic resource] /edited by Randy Q. Cron, Edward M. Behrens. - Second edition. - Cham :Springer International Publishing :2024. - xvi, 628 p. :ill. (some col.), digital ;24 cm. - Advances in experimental medicine and biology,v. 14482214-8019 ;. - Advances in experimental medicine and biology ;780..

1. Cytokines in cytokine storm syndromes -- 2. History of HLH -- 3. The history of macrophage activation syndrome in autoimmune diseases -- 4. Clinical features of cytokine storm syndromes -- 5. Laboratory features and pathology of cytokine storm syndromes -- 6. Criteria for cytokine storm syndromes -- 7. Familial HLH genetics -- 8. Secondary HLH genetics -- 9. Genetics of macrophage activation syndrome in systemic juvenile idiopathic arthritis -- 10. CD8+ T cell biology in cytokine storm syndromes -- 11. Immunology of cytokine storm syndromes: Natural killer cells -- 12. Myeloid cells in the immunopathogenesis of cytokine storm syndrome -- 13. Cytokine storm -- 14. Primary immunodeficiencies -- 15. Infectious triggers of cytokine storm syndromes: Herpes virus family (non-EBV) -- 16. CSS associated with Epstein Barr Virus -- 17. Hemorrhagic Fever and other viruses -- 18. Cytokine storm syndrome as a manifestation of primary HIV infection -- 19. Bacteria-associated cytokine storm syndrome -- 20. Zoonoticbacterial infections triggering cytokine storm syndrome -- 21. Parasitic and fungal triggers -- 22. COVID-19 pneumonia and cytokine storm syndrome -- 23. Cytokine storm associated with Systemic Juvenile Idiopathic Arthritis -- 24. Systemic lupus erythematosus -- 25. Kawasaki disease -- 26. The intersections of autoinflammation and cytokine storm -- 27. Other rheumatic triggers -- 28. Multisystem Inflammatory Syndrome in children -- 29. Hemophagocytic lymphohistiocytosis in the context of hematological malignancies and solid tumors -- 30. Cytokine storm and sepsis-induced Multiple Organ Dysfunction Syndrome -- 31. The cytokine storm of Multicentric Castleman Disease -- 32. Cytokine storm syndromes associated with pregnancy and therapeutics -- 33. fHLH models -- 34. sHLH models -- 35. Etoposide therapy of CSS -- 36. IL-1 family blockade -- 37. IL-6 blockade -- 38. IFNy blockade -- 39. JAK inhibitors -- 40. Other immunomodulatory HLH treatments -- 41. Salvage therapy for HLH.

Cytokine Storm Syndromes, including HLH and MAS, are frequently fatal disorders, particularly if not recognized early and treated during presentation. The genetics of Cytokine Storm Syndromes are being defined with many of the risk alleles giving rise to mutations in the perforin-mediated cytolytic pathway used by CD8 cytotoxic T cells and natural killer cells. These are being studied using murine models. Up to 10% of the general population may carry risk alleles for developing Cytokine Storm Syndromes, and Cytokine Storm Syndromes are being increasingly recognized around the world in pediatric and adult hospitals. A variety of infectious, rheumatic, and oncologic triggers are commonly associated with Cytokine Storm Syndromes, but understanding this disorder is critical for all researchers and physicians to ensure timely and appropriate therapy. This second edition addresses all aspects of the disorder, from genetics, pathophysiology, and ongoing research, to clinical presentations, risk factors and treatment. New-to-this-edition features include dedicated chapters on severe COVID-19 CSS, and post-COVID CSS of multi-system inflammatory syndrome in children (MIS-C) In addition, novel topics including CSS associated with Castleman disease, pregnancy, therapeutics, transplantation, and cardiac bypass, as well as treatment with JAK inhibitors are addressed.

ISBN: 9783031598159

Standard No.: 10.1007/978-3-031-59815-9doiSubjects--Topical Terms:

787581
Cytokines and Growth Factors.

LC Class. No.: RC582

Dewey Class. No.: 616.97

Cytokine storm syndrome
LDR:04511nam a22003615a 4500 001 1134518
003 DE-He213
005 20240809130225.0
006 m d
007 cr nn 008maaau
008 241213s2024 sz s 0 eng d
020 $a 9783031598159 $q (electronic bk.)
020 $a 9783031598142 $q (paper)
024 7 $a 10.1007/978-3-031-59815-9 $2 doi
035 $a 978-3-031-59815-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC582
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
072 7 $a MJCM $2 thema
082 0 4 $a 616.97 $2 23
090 $a RC582 $b .C997 2024
245 0 0 $a Cytokine storm syndrome $h [electronic resource] / $c edited by Randy Q. Cron, Edward M. Behrens.
250 $a Second edition.
260 $a Cham : $c 2024. $b Springer International Publishing : $b Imprint: Springer,
300 $a xvi, 628 p. : $b ill. (some col.), digital ; $c 24 cm.
347 $a text file $b PDF $2 rda
490 1 $a Advances in experimental medicine and biology, $x 2214-8019 ; $v v. 1448
505 0 $a 1. Cytokines in cytokine storm syndromes -- 2. History of HLH -- 3. The history of macrophage activation syndrome in autoimmune diseases -- 4. Clinical features of cytokine storm syndromes -- 5. Laboratory features and pathology of cytokine storm syndromes -- 6. Criteria for cytokine storm syndromes -- 7. Familial HLH genetics -- 8. Secondary HLH genetics -- 9. Genetics of macrophage activation syndrome in systemic juvenile idiopathic arthritis -- 10. CD8+ T cell biology in cytokine storm syndromes -- 11. Immunology of cytokine storm syndromes: Natural killer cells -- 12. Myeloid cells in the immunopathogenesis of cytokine storm syndrome -- 13. Cytokine storm -- 14. Primary immunodeficiencies -- 15. Infectious triggers of cytokine storm syndromes: Herpes virus family (non-EBV) -- 16. CSS associated with Epstein Barr Virus -- 17. Hemorrhagic Fever and other viruses -- 18. Cytokine storm syndrome as a manifestation of primary HIV infection -- 19. Bacteria-associated cytokine storm syndrome -- 20. Zoonoticbacterial infections triggering cytokine storm syndrome -- 21. Parasitic and fungal triggers -- 22. COVID-19 pneumonia and cytokine storm syndrome -- 23. Cytokine storm associated with Systemic Juvenile Idiopathic Arthritis -- 24. Systemic lupus erythematosus -- 25. Kawasaki disease -- 26. The intersections of autoinflammation and cytokine storm -- 27. Other rheumatic triggers -- 28. Multisystem Inflammatory Syndrome in children -- 29. Hemophagocytic lymphohistiocytosis in the context of hematological malignancies and solid tumors -- 30. Cytokine storm and sepsis-induced Multiple Organ Dysfunction Syndrome -- 31. The cytokine storm of Multicentric Castleman Disease -- 32. Cytokine storm syndromes associated with pregnancy and therapeutics -- 33. fHLH models -- 34. sHLH models -- 35. Etoposide therapy of CSS -- 36. IL-1 family blockade -- 37. IL-6 blockade -- 38. IFNy blockade -- 39. JAK inhibitors -- 40. Other immunomodulatory HLH treatments -- 41. Salvage therapy for HLH.
520 $a Cytokine Storm Syndromes, including HLH and MAS, are frequently fatal disorders, particularly if not recognized early and treated during presentation. The genetics of Cytokine Storm Syndromes are being defined with many of the risk alleles giving rise to mutations in the perforin-mediated cytolytic pathway used by CD8 cytotoxic T cells and natural killer cells. These are being studied using murine models. Up to 10% of the general population may carry risk alleles for developing Cytokine Storm Syndromes, and Cytokine Storm Syndromes are being increasingly recognized around the world in pediatric and adult hospitals. A variety of infectious, rheumatic, and oncologic triggers are commonly associated with Cytokine Storm Syndromes, but understanding this disorder is critical for all researchers and physicians to ensure timely and appropriate therapy. This second edition addresses all aspects of the disorder, from genetics, pathophysiology, and ongoing research, to clinical presentations, risk factors and treatment. New-to-this-edition features include dedicated chapters on severe COVID-19 CSS, and post-COVID CSS of multi-system inflammatory syndrome in children (MIS-C) In addition, novel topics including CSS associated with Castleman disease, pregnancy, therapeutics, transplantation, and cardiac bypass, as well as treatment with JAK inhibitors are addressed.
650 2 4 $a Cytokines and Growth Factors. $3 787581
650 2 4 $a Diseases. $3 636013
650 2 4 $a Molecular Genetics. $3 1389888
650 1 4 $a Immunology. $3 592892
650 0 $a Cytokines. $3 581465
650 0 $a Immunologic diseases. $3 592893
700 1 $a Behrens, Edward M. $e editor. $3 1309692
700 1 $a Cron, Randy Q. $e editor. $3 1309691
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
830 0 $a Advances in experimental medicine and biology ; $v 780. $3 881230
856 4 0 $u https://doi.org/10.1007/978-3-031-59815-9
950 $a Biomedical and Life Sciences (SpringerNature-11642)